R

Replimune Group

Develops oncolytic viral immunotherapies for cancer

Analyst 2 - Analytical Development

Bioprocess & BiomanufacturingPosted on Nov 13
Full-timePark Dr, Abingdon, UKNo salary listed

About the Job

Requirements

  • A minimum of 1 year of relevant laboratory experience is required.
  • An interest in biological science is essential.
  • Experience in any of cell culture, enzyme-linked immunosorbent assay, polymerase chain reaction, or chromatography is required.
  • Good information technology skills in Microsoft Word, Excel, and Outlook are required.
  • The candidate must be self-motivated, organized, and able to manage time effectively.
  • The candidate must be able to work independently and as part of a small team, communicate effectively, and work flexibly to meet varying workloads.

Responsibilities

  • Perform routine polymerase chain reaction, enzyme-linked immunosorbent assay, chromatography, and cell-based analytical tests to support Process Development, Analytical Development, Research, and Quality Control testing.
  • Support analytical method development and product characterization projects.
  • Prepare laboratory chemical reagents and biological assay standards and controls for routine testing and development projects.
  • Perform internal periodic maintenance, calibration, and verification of laboratory equipment.
  • Perform general laboratory housekeeping, including maintaining laboratory consumable stock levels.
  • Work in accordance with Good Manufacturing Practice, company procedures, and health and safety practices.
  • Author, update, and adhere to equipment and method standard operating procedures as required.
  • Review assay sheets, laboratory books, and Good Manufacturing Practice documentation.
  • Train team members in equipment usage and maintenance.

Desired Qualifications

  • A Biological Sciences Bachelor of Science degree is preferred.
  • Experience working in a Good Manufacturing Practice laboratory environment is beneficial.

About the Company

Replimune Group

Develops oncolytic viral immunotherapies for cancer

Replimune develops cancer therapies that use engineered viruses (oncolytic immunotherapies) to attack tumors. These treatments selectively infect cancer cells, causing their destruction, and at the same time stimulate the immune system to recognize and fight tumors. By combining multiple methods of action, Replimune aims to boost the effectiveness of existing immune checkpoint inhibitors and create a stronger anti-tumor response. The company focuses on research, development, and clinical testing, and plans to earn revenue through partnerships, licensing, and eventual sales of approved therapies. Its goal is to deliver workable cancer treatments by validating safety and efficacy in clinical trials and bringing these therapies to patients with various cancers.

Company size
201-500
Company stage
IPO
Headquarters
Woburn, MA
Founded
2015

Recently Posted Jobs

Explore more opportunities at Replimune Group

See more jobs